共 50 条
- [41] A Benefit-Risk Assessment of Caffeine as an Analgesic Adjuvant [J]. Drug Safety, 2001, 24 : 1127 - 1142
- [42] Benefit-Risk Assessment of Orlistat in the Treatment of Obesity [J]. Drug Safety, 2014, 37 : 597 - 608
- [43] Benefit-risk profile of new inhalation anesthetics [J]. ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, 2001, 36 (06): : 362 - 365
- [44] Benefit-Risk Assessment of Orlistat in the Treatment of Obesity [J]. DRUG SAFETY, 2014, 37 (08) : 597 - 608
- [45] SALICYLATES - IMPROVED BENEFIT-RISK IN ANIMAL STUDIES [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1981, 11 (06): : 720 - 720
- [46] Benefit-Risk Assessment of Raloxifene in Postmenopausal Osteoporosis [J]. Drug Safety, 2005, 28 : 721 - 730
- [48] Benefit-risk analysis of hormone replacement therapy [J]. GYNAKOLOGE, 1997, 30 (04): : 314 - 325
- [49] A Benefit-Risk Assessment of Basiliximab in Renal Transplantation [J]. Drug Safety, 2004, 27 : 91 - 106
- [50] Benefit-risk analysis for prescribing triphenylmethane dyes [J]. HAUTARZT, 2008, 59 (10): : 833 - 837